BARRETT’S
ESOPHAGUS
Presented by –
ALOK KUMAR YADAV
ROLL NO. 14
INDEX
 INTRODUCTION
 ASSOCIATED RISK FACTORS
 PATHOGENESIS
 SIGN AND SYMPTOMS
 DIAGNOSIS
 MANAGEMENT
INTRODUCTION
Barrett esophagus is a complication of chronic GERD
that is characterised by a intestinal metaplasia within
the esophageal squamous mucosa and is associated
with an increased risk of cancer.
Also called as – Barrett syndrome/ Columnar Lined
Lower Oesophagus
ASSOCIATED RISK FACTORS
10% cases of symptomatic GERD
2% general population
 More common in white males ( 40-60 yrs )
Obese population
PATHOGENESIS
Chronic
GERD
Incresed acid
exposure
ESOPHAGEAL
MUCOSAL INJURY
AND SQUAMOUS
EPITHELIAL
DAMAGE
Acute and
chronic
inflammatory
changes
Reflux
esophagitis
Recovery (
metaplastic
changes )
BARRETT’S
ESOPHAGUS
MAY LEAD TO
ADENOCARCINOM
A OF THE
ESOPHAGUS
DYSPLASIA
MORPHOLOGY
Red velvety mucosa extending upward
from the gastroesophageal junction.
Normal squamous epithelial cell changes into
goblet cell .
Types
1. Long
segment
(>3 cm )
2. Short
segment
(<3 cm )
SIGN AND SYMPTOMS
Frequent and longstanding heartburn
Dysphagia
Hematemesis
Pain under the breastbone
Weight loss
DIAGNOSTIC APPROACHES
ENDOSCOPY ( esophago-gastro-duodenoscopy)
BIOPSY( presence of goblet cell is seen )
MANAGEMENT
Surveillance by periodic endoscopy with biopsy.
PPI’S and NSAIDS
Esophagectomy
Mucosal resection
Photodynamic therapy
endoscopic mucosectomy
PREVENTION
SUMMARY
Barrett esophagus develops in patient with chronic
GERD and
Represents columnar metaplasia of the esophagial
squamous mucosa
Barrett esophagus is a risk factor for development of
esophageal carcinoma
REFERENCES
Pathologic basis of disease by ROBBINS AND
COTRAN tenth edition volume 2 .
NATIONAL INSTITUTE OF HEALTH ( niddk.nih.gov)
Image courtsy – PINTEREST
THANK YOU

Barrett’s esophagus.pptx a brief discription